Brazil
7 Vaccines Approved for Use in Brazil
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)
Approved in 49 countries
3 trials in 1 country
Approval Source: bio.fiocruz.br
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 91 countries
29 trials in 12 countries
Approval Source: gov.br
Inactivated
13 in Clinical Trials in Brazil
Protein Subunit
Clover
SCB-2019
12 trials in 11 countries
VLP
Medicago
Covifenz
Approved in 1 country
6 trials in 6 countries
DNA
Inovio
INO-4800
9 trials in 9 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
AZD2816
2 trials in 2 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Non Replicating Viral Vector
ReiThera
GRAd-COV2
5 trials in 12 countries
Inactivated
Chinese Academy of Medical Sciences
Inactivated (Vero Cells)
8 trials in 4 countries
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
37 trials in 9 countries
Non Replicating Viral Vector
Mahidol University
NDV-HXP-S
7 trials in 3 countries
Protein Subunit
University of Saskatchewan
COVAC-1
RNA
SENAI CIMATEC